- Home
- YETI vs VRDN Comparison
YETI vs VRDN Comparison
Compare YETI & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YETI | VRDN |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.7B |
| IPO Year | 2016 | 2014 |
Fundamental Metrics
Financial Performance| Metric | YETI | VRDN |
|---|---|---|
| Price | $38.94 | $29.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 13 |
| Target Price | ★ $46.54 | $41.17 |
| AVG Volume (30 Days) | ★ 1.4M | 1.1M |
| Earning Date | 05-21-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.03 | N/A |
| Revenue | ★ $1,868,494,000.00 | $5,706,000.00 |
| Revenue This Year | $9.13 | $13.90 |
| Revenue Next Year | $7.16 | $284.55 |
| P/E Ratio | $19.90 | ★ N/A |
| Revenue Growth | ★ 2.11 | N/A |
| 52 Week Low | $26.61 | $9.90 |
| 52 Week High | $51.29 | $34.29 |
Technical Indicators
Market Signals| Indicator | YETI | VRDN |
|---|---|---|
| Relative Strength Index (RSI) | 26.55 | 50.36 |
| Support Level | $30.87 | $21.50 |
| Resistance Level | $50.74 | $33.71 |
| Average True Range (ATR) | 1.90 | 1.59 |
| MACD | -0.71 | 0.16 |
| Stochastic Oscillator | 3.97 | 77.46 |
Price Performance
Historical ComparisonAbout YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).